So again, yes or no, do you believe that clinical trial diversity is critically important? That’s an easy one.” “Well, if you are talking about a trial of sickle cell disease, are we saying that we need to have white people in a trial of sickle cell,” Makary responded.
What was an MIT mathematician doing at a vaccine injury roundtable in 2021? How, four years later, did he end up on the Advisory Committee on Immunization Practices (ACIP)? What about the comments he made and questions he asked at the last ACIP meeting - were they reasonable?
In an Amsterdam jail cell, the walls are covered in expressions of love. “Catalina, my love!” “I miss my daughter.” I can see why. Once your phone is taken away, your mind immediately wanders to your loved ones. I asked the guard, “Can I call my wife?” “Your lawyer can.”
In my time as a medical oncologist and pharmaceutical industry executive, overseeing hundreds of clinical trials and supporting over a dozen approvals of new cancer treatments around the world, I often told my teams a Russian joke.
I saw Dr Pierre Kory at an event in March called Summit for Truth in Rochester, New York. I asked him how he could so unequivocally exclude the contribution of measles to the patient's death. And then we had a brief exchange. Let's listen.